EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MAP3K1: A Multifunctional Kinase at the Crossroads of Cancer Progression and Tumor Suppression

Lelisse T Umeta iD, Amarnath Natarajan iD

Cells · 28.03.2026 · 15 (7) · 604

DOI: 10.3390/cells15070604 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 28.03.2026. Verfasst von Lelisse T Umeta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE 68198, USA. Hauptthemen laut MEDLINE: Neoplasms, MAP Kinase Kinase Kinase 1, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Foundation for the National Institutes of Health, NIH https://ror.org/044zkrt47.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) possesses dual enzymatic functions, i.e., kinase and E3 ubiquitin ligase activities, orchestrating proliferation, survival, apoptosis, DNA damage response, and immune modulation. Recent genomic and mechanistic studies have revealed MAP3K1’s paradoxical, context-dependent roles as both an oncogene and a tumor suppressor. We discuss MAP3K1’s multidomain architecture, featuring an N-terminal RING and PHD domain (E3 ligase activity), a TOG domain (microtubule dynamics), and a C-terminal kinase domain, enabling the integration of c-jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (p38 MAPK), extracellular signal-regulated kinase (ERK), and nuclear factor kappa B (NF-κB) signaling pathways. MAP3K1 functions as a molecular switch balancing survival and apoptosis, with caspase-3 cleavage at Asp878 activating pro-apoptotic JNK/p38 signaling. Genomic analyses across >35 cancer types reveal MAP3K1 alterations at frequencies of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMAP Kinase Kinase Kinase 1Disease ProgressionHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

E3 ligaseMAP3K1kinaseoncogenesignalingtumor suppressor

Substanzen

MAP Kinase Kinase Kinase 1MAP3K1 protein, human

Autor:innen und Institutionen

  • Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Division of Pharmaceutical Sciences, James L. Winkle, College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA.

ORCID-Profile: Lelisse T Umeta, Amarnath Natarajan

Förderung

  • NCI NIH HHS
  • Foundation for the National Institutes of Health
  • NIH https://ror.org/044zkrt47

Zitieren

APA

Umeta, L. T., & Natarajan, A. (2026). MAP3K1: A Multifunctional Kinase at the Crossroads of Cancer Progression and Tumor Suppression. Cells, 15(7), 604. https://doi.org/10.3390/cells15070604

Vancouver

Umeta LT, Natarajan A. MAP3K1: A Multifunctional Kinase at the Crossroads of Cancer Progression and Tumor Suppression. Cells. 2026;15(7):604. doi:10.3390/cells15070604

BibTeX
@article{Umeta2026,
  author = {Umeta, Lelisse T and Natarajan, Amarnath},
  title = {MAP3K1: A Multifunctional Kinase at the Crossroads of Cancer Progression and Tumor Suppression},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {604},
  doi = {10.3390/cells15070604}
}
Kostenlos starten →